[2] Hodgin JB, Bitzer M, Wickman L, Afshinnia F, Wang SQ, O’Connor C, Yang Y, Meadowbrooke C, Chowdhury M, Kikuchi M, Wiggins JE, Wiggins RC: Glomerular aging and focal global glomerulosclerosis: A podometric perspective. J Am Soc Nephrol 26:...
FSGS 的病变必须要与局灶性全球性肾小球硬化(FGGS)相鉴别,也可称为全球肾小球硬化(Global glomerulosclerosis),这通常是正常衰老和/或慢性高血压引起的肾小球病变,并且可以叠加在 FSGS 之上,特别是在老年患者中。 与FSGS(其中硬化仅限于病变肾小球的一部分)相比,FGGS 的硬化...
球性(Global):就一个肾小球而言, 整个 2、(50%)毛细血管丛受累 节段性(Segmental):就一个肾小球而言,仅部分小叶受累。,FSGS的病理特征,病变仅限于双侧肾脏的一部份肾小球,而这部分肾小球的病变也仅位于毛细血管袢的个别节段,偶而波及一个完整的肾小球,病变性质因病变和病程的不同。包括局灶性肾小球节段性...
This is a global study involving approximately 300 patients. If the study is right for you and you choose to participate, all study-related care and study medication will be provided at no cost to you during your participation. What is FSGS? About Focal Segmental Glomerulosclerosis (FSGS) FSGS...
邮箱:info@globalmarketmonitor.com.cn 目录 第一章 中国局灶性肾小球硬化症 (FSGS) 治疗药物行业基本概述 1.1 局灶性肾小球硬化症 (FSGS) 治疗药物行业定义概述 1.1.1 局灶性肾小球硬化症 (FSGS) 治疗药物行业定义 1.1.2 局灶性肾小球硬化症 (FSGS) 治疗药物行业发展历史 ...
Overall, sex, baseline eGFR, proteinuria and the degree of focal and global glomerulosclerosis play a more important role in estimating the prognosis of patients with FSGS, than merely the FSGS etiology.Deleersnijder DriesCleenders EvertCoemans Maarten...
Therefore, it is not uncommon that after an initial biopsy showing no clear FSGS lesion a subsequent biopsy taken months or years later shows clear FSGS lesions [29]. With progression of the disease more widespread and global glomerulosclerosis develops together with tubulointerstitial and vascular ...
14、ey Disease: Improvement Global Outcomes (KDIGO) 1.只有当FSGS呈現NS的临床症状时,才推荐激素与免疫抑制剂治疗 (1C)。 2.建议泼尼松(龙)1mg/kg(最大剂量80mg)qd或隔日2mg/kg(最大剂量120mg)(2C)。 3.建议最初大剂量激素给予最短时间为4周;最初大剂量直至完全缓全缓解; 如能耐受,最初大剂量最...
Few North American studies have addressed modern trends and none has applied the 2018 Kidney Disease Improving Global Outcomes (KDIGO) pathologic classification... S Kudose,D Santoriello,AS Bomback,... - 《Kidney International》 被引量: 0发表: 2020年 Emerging therapeutic strategies for minimal ch...
足细胞的免疫治疗 1.激素; 2.免疫抑制剂; 3.巴利昔单抗; 4.血液净化治疗; 5.微化中药; 6.免疫保护; 7.抗凝治疗; 8.ACEI、ARB; 局灶节段性肾小球硬化(FSGS)治疗 Kidney Disease: Improvement Global Outcomes (KDIGO) 1.只有当FSGS呈現NS的临床症状时,才推荐激素与免疫抑制剂治疗 (1C)。 2.建议泼尼...